H-1B Wage Lookup

Data through FY2026 Q3 (Jun 30, 2026)

Y-mAbs Therapeutics Inc.

Company profile for Y-mAbs Therapeutics Inc. covers 4 filings across the reporting window. FY2025 certified median offer: $180,000.

FY2025 certified median
$180,000
Total filings
4
FY2025 25th–75th percentile
$180,000–$180,000
Top job title
Director, SEC Reporting & Technical Accounting
Certified offers by fiscal year
Fiscal yearFilingsMedian25th percentile75th percentile
FY20242$90,500$90,250$90,750
FY20252$180,000$180,000$180,000

FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.

Median offer by fiscal year

Certified median offer, Y-mAbs Therapeutics Inc.FY2024 $90,500; FY2025 $180,000$0$60,000$120,000$180,000FY2024$90,500FY2025$180,000Certified median offer, Y-mAbs Therapeutics Inc.FY2024 $90,500; FY2025 $180,000$0$60k$120k$180kFY2024$90,500FY2025$180,000
Certified H-1B LCAs, $15k–$2M, DOL OFLC

Top titles

  1. Director, SEC Reporting & Technical Accounting2 filings
  2. Research Associate1 filings
  3. Research Scientist1 filings

Top cities

  1. Nutley2 filings
  2. Princeton2 filings

Employer and title details